Alsya J. Affandi

2.0k total citations
30 papers, 743 citations indexed

About

Alsya J. Affandi is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Alsya J. Affandi has authored 30 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 10 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Alsya J. Affandi's work include Immunotherapy and Immune Responses (11 papers), Systemic Sclerosis and Related Diseases (9 papers) and Immune cells in cancer (7 papers). Alsya J. Affandi is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Systemic Sclerosis and Related Diseases (9 papers) and Immune cells in cancer (7 papers). Alsya J. Affandi collaborates with scholars based in Netherlands, United States and Singapore. Alsya J. Affandi's co-authors include Timothy R. D. J. Radstake, Romy Christmann, Robert Lafyatis, Joke M. M. den Haan, Joanna Grabowska, Wioleta Marut, Cristina M. Padilla, Allison L. Mathes, Giuseppina Stifano and Giuseppina Farina and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Controlled Release.

In The Last Decade

Alsya J. Affandi

30 papers receiving 733 citations

Peers

Alsya J. Affandi
Sashidhar Nakerakanti United States
Allison L. Mathes United States
S. Saks United States
James S. Rush United States
Assi Levi Israel
Sashidhar Nakerakanti United States
Alsya J. Affandi
Citations per year, relative to Alsya J. Affandi Alsya J. Affandi (= 1×) peers Sashidhar Nakerakanti

Countries citing papers authored by Alsya J. Affandi

Since Specialization
Citations

This map shows the geographic impact of Alsya J. Affandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alsya J. Affandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alsya J. Affandi more than expected).

Fields of papers citing papers by Alsya J. Affandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alsya J. Affandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alsya J. Affandi. The network helps show where Alsya J. Affandi may publish in the future.

Co-authorship network of co-authors of Alsya J. Affandi

This figure shows the co-authorship network connecting the top 25 collaborators of Alsya J. Affandi. A scholar is included among the top collaborators of Alsya J. Affandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alsya J. Affandi. Alsya J. Affandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rodríguez, Ernesto, Alsya J. Affandi, Jan Verhoeff, et al.. (2024). In‐depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations. Cancer Science. 115(7). 2170–2183. 4 indexed citations
3.
Boes, Marianne, et al.. (2024). Comparing DC subsets in solid tumors: what about DC3s?. PubMed. 5(1). ltaf021–ltaf021. 1 indexed citations
4.
Carvalheiro, Tiago, Wioleta Marut, M Inês Pascoal Ramos, et al.. (2024). Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis. Journal of Autoimmunity. 146. 103219–103219. 2 indexed citations
5.
Affandi, Alsya J., Bárbara Mesquita, Katarzyna Olesek, et al.. (2024). Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity. International Journal of Pharmaceutics. 660. 124254–124254. 7 indexed citations
6.
Ee, Thomas van, Alsya J. Affandi, Ernesto Rodríguez, et al.. (2023). Spatial immune composition of tumor microenvironment in patients with pancreatic cancer. Cancer Immunology Immunotherapy. 72(12). 4385–4397. 8 indexed citations
7.
Grabowska, Joanna, Valentine Léopold, Katarzyna Olesek, et al.. (2023). Platelets interact with CD169+ macrophages and cDC1 and enhance liposome-induced CD8+ T cell responses. Frontiers in Immunology. 14. 1290272–1290272. 7 indexed citations
8.
Spiekstra, Sander W., Alsya J. Affandi, Henk P. Roest, et al.. (2023). An Organotypic Human Lymph Node Model Reveals the Importance of Fibroblastic Reticular Cells for Dendritic Cell Function. Tissue Engineering and Regenerative Medicine. 21(3). 455–471. 10 indexed citations
9.
Olesek, Katarzyna, Joanna Grabowska, Alsya J. Affandi, et al.. (2022). Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses. Frontiers in Immunology. 13. 842241–842241. 14 indexed citations
10.
Servaas, Nila H., Sanne Hiddingh, Eleni Chouri, et al.. (2022). Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c + Dendritic Cell Dysregulation in Systemic Sclerosis. Arthritis & Rheumatology. 75(2). 279–292. 9 indexed citations
11.
Affandi, Alsya J., Katarzyna Olesek, Joanna Grabowska, et al.. (2021). CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity. Frontiers in Immunology. 12. 697840–697840. 40 indexed citations
12.
Grabowska, Joanna, Alsya J. Affandi, Katarzyna Olesek, et al.. (2021). Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion. Journal of Controlled Release. 331. 309–320. 24 indexed citations
13.
Grabowska, Joanna, Alsya J. Affandi, Chun Yin Jerry Lau, et al.. (2020). Optimization of Liposomes for Antigen Targeting to Splenic CD169+ Macrophages. Pharmaceutics. 12(12). 1138–1138. 19 indexed citations
14.
Servaas, Nila H., Fatiha Zaaraoui‐Boutahar, Catharina G. K. Wichers, et al.. (2020). Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis. Journal of Autoimmunity. 117. 102574–102574. 23 indexed citations
15.
Grabowska, Joanna, Alsya J. Affandi, Hakan Kalay, et al.. (2020). 849 Optimization of a GM3-containing liposomal vaccine that delivers antigen to CD169+ splenic macrophages. SHILAP Revista de lepidopterología. A506.2–A506. 1 indexed citations
16.
Grabowska, Joanna, et al.. (2018). CD169+ Macrophages Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the Immune System. Frontiers in Immunology. 9. 2472–2472. 86 indexed citations
17.
Affandi, Alsya J., Tiago Carvalheiro, Timothy R. D. J. Radstake, & Wioleta Marut. (2017). Dendritic cells in systemic sclerosis: Advances from human and mice studies. Immunology Letters. 195. 18–29. 23 indexed citations
19.
Veenbergen, Sharon, M.B. Bennink, Alsya J. Affandi, et al.. (2011). A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis. Annals of the Rheumatic Diseases. 70(12). 2167–2175. 20 indexed citations
20.
Christmann, Romy, Sarah A. Pendergrass, Cristina M. Padilla, et al.. (2011). Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. Arthritis & Rheumatism. 63(6). 1718–1728. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026